___

• 1. R.M.O’Beien, K.A. Byron, G.A.Varigos and W.R.Thomas. House dust mite immunotherapy results in a decrease in Derp 2-specific İFN-g and İL-4 expression by circulating T lymphocytes. Clinical and Experimental Alergy, 1997; Volume 27, pages 46-51.2. Gurka G, Rocklin R. İmmunologic responses during allergen-specific immunotherapy for respiratory allergy. Ann Allergy 1988;61:239-43.3. Gürbüz, L.: ev tozu akarcıklarının bronş astmasındaki yeri. I. Alerjik Hastalıklar sempozyumu, Ankara, s. 157-162,1985.4. Kerr, J.W., Murchinson, L.E.: A controlled trial of polen adsorbate in the treatment of hay fever.5. Dullaers M, Schuijs MJ, Willart M, Fierens K, Van Moorleghem J, Hammad H, Lambrecht BN. House dust mite-driven asthma and allergen-specific T cells depend on B cells when the amount of inhaled allergen is limiting. J Allergy Clin Immunol. 2017 Jul;140(1):76-88.e7. doi: 10.1016/j.jaci.2016.09.020. Epub 2016 Oct 13.6. Reeves, R., and N.S. Magnuson. Mechanisms regulating translent expression of mammalian cytokine genes and cellular oncogenes. Progress in Nucleic Acid Research and Molecular Biology 38:241-282,1990.7. Van Snick, J. İnterleukin-6: an overview Annual Review of Immunotherapy 8:253-278,1990.8. Specific Review of İmmunologyb 5:429-460-,198750. 9. DeKruff RH, Fan Y, Umetsu DT. IL-4 Synthesis by in vivo primed keyhole limpet hemocyanin-specific CD4 T cells. J Immunol 1992;149:3468-76.10. HayGlass KT, Stefura BP. Anti interferon-g treatment blocks the IgE responses. J Exp Med 1991;173:279-85.11. Canorica GW, Mingari MC, Melioli G, Colombatti M, Moretta L. Imbalance of T cell subpopulations in paients with atopic diseases and effect of specific immunotherapy. J Immunol 1979;123:2669-72.12. Walker C, Bode E, Boer L, Hansel TT, Blasen K, Virchow JC. Allergic and non-allergic asthmatics have distinct patterns of T-cell activation and cytokin production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis 1992;146:109-15.13. Robinson LD. Gamma interferon induced changes in CD4/CD8 populations in hyper IgE syndrome J Allergey Clin Immunol 1993;91:141.14. Gideon Lack, Harold S. Nelson. Rush immunotherapy results in alergen-specific alterations in lymphocyte function and interferon-g production in CD4 T cells. J Allergy Clin Immunol 1997;99:530-8.15. Natziger J, Arock M, Gulliosson J.J, Wietzerbin J. Specific highaffinity receptors for interferon-g on Mouse bone marrow-derived mast cells: inhibitory effect on interferon-g on mast cell precursors. Eur J Immunol 1990;20:113-7.16. Mosmann, T.R., H. Cherwinski, M.W. Bond, M.A. Giedlin, Two types of murine hepler T cell. I.Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:234817. Coffman, R., and J. Carty. 1986. AT cell activity that enhances polyclonal IgE production and its inhibition by interferon-g. J. Immunol. 136:949.18. Rabin, E., J. Mond, J. Ohara, and W. Paul. 1986. İnterferon-g inhibits the action of B cell stimulatory factor (BSF)-1 on resting Bcells. J Immunol. 137:1573.19. Reynolds, D., W. Boom, and Abbas. 1987. Inhibition of B lymphocyte activation by interferon-g J. Imumunol. 139:767.20. Secrist H, Chelen CJ, Wen Yan, Marshall JD, Umetsu DT. Allergen immunotherapy decreases interleukin-4 production in CD4 Tcells from allergic individuals. J Exp Med 1993;178:2123-30.21. Kay, A.B. mechanisms and treatment of allergic rhinitis. In Kerr, A.G.; Scott-brown’s otolaryngology, vol 4, pp:93-114, Butterworth, 1987.22. Gajewski TF, Fitch FW. anti-proliferative effect of İNF-g inhibits the proliferation of Th2 but not Th1, murine hepler T lymphocyte clanes J Immunol 1988;140:4245-52.23. Moore KW, Vieira P, Fiorention DF,Trounstine ML., Khan TA, Mosmann TR. Homology of cytokine synthesis inhibitory factor (IL-10) to the EBV gene BCRFI. Science 1990;248:1230-4.24. Mosmann TR, Bond MW, Coffman RL, Ohana J, paul WE. T cell and mast cell lines respond to B cell stimulatory factor-1. Proc Natl Acad Sci 1986;83:5654-8.25. Fenkelman FD, Holmes J., Katona ID et al. Lymphokine control of in vivo immunglobulin isotype selection. Annu Rev Immunol 1990,8:303-33.26. Jutel M, Hichler WF, Skrbic D, Urwyler A, Dahinden C, Muller UR. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and incresase of İFN-g secretion allergen-stimulated T cell cultures. J Immunol 1995;154:4187-94